Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LBH589 in Metastatic MTC and Radioiodine Resistant DTC
NCT01013597Phase 2Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Jan 2010
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of panobinostat in Medullary Thyroid Cancer (MTC), differentiated thyroid cancer (DTC), sponsored by University of Wisconsin–Madison. Started Jan 2010; status: completed.
02
Drugs
panobinostat
03
Conditions
Medullary Thyroid Cancer (MTC)differentiated thyroid cancer (DTC)
Beyond the preview
Go deeper on NCT01013597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01013597.